Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition
Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition Eindhoven, May 11th 2021 - Sirius Medical, a medical device start-up developing the next generation of tumor localization technology, today announced that medical device...
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion Amsterdam, 17 February 2021 – Digital R&D simulation software platform RheoCube has attracted an investment of over 2 million USD. This funding...
Holland Capital invests in cards PLM Solutions
Holland Capital invests in cards PLM Solutions Amsterdam / Best, January 22, 2021 - cards PLM Solutions, Product Lifecycle Management (PLM) solutions provider, is taking the next step towards growth through the investment of private equity firm Holland Capital. The...
Dimensys receives capital injection from Holland Capital to aid further growth
Dimensys receives capital injection from Holland Capital to aid further growth Amsterdam/’s-Hertogenbosch, January 14, 2021 - Holland Capital invests in Dimensys, a specialized SAP Partner in the field of Asset and Product Lifecycle Management (PLM). Since its...
Intercept is pursuing an international growth strategy with Holland Capital
Intercept is pursuing an international growth strategy with Holland Capital Amsterdam / Zwolle, January 11, 2021 - Intercept, a leading Microsoft Cloud Solution Provider (CSP), will receive a substantial capital injection from Holland Capital. Intercept helps...
Holland Capital invests in Purple for international expansion of digital storytelling
Holland Capital invests in Purple for international expansion of digital storytelling Amsterdam, Halfweg, 5th of January 2021 – Purple, the Amsterdam-based storytelling agency, is receiving funding from private equity provider Holland Capital. This investment will...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01